Carlos K H Wong1, Jing Chen2, Charlotte L Y Yu3, Mansy Sham3, Cindy L K Lam3. 1. Department of Family Medicine and Primary Care, The University of Hong Kong, 3/F, Ap Lei Chau Clinic, 161 Ap Lei Chau Main Street, Ap Lei Chau, Hong Kong. Electronic address: carlosho@hku.hk. 2. School of Nursing, The University of Hong Kong, Rm 306, Faculty of Medicine Building, William M.W. Mong Block, 21 Sassoon Road, Pokfulam, Hong Kong. 3. Department of Family Medicine and Primary Care, The University of Hong Kong, 3/F, Ap Lei Chau Clinic, 161 Ap Lei Chau Main Street, Ap Lei Chau, Hong Kong.
Abstract
OBJECTIVES: To critically appraise the measurement properties of standardized health-related quality of life (HRQOL) instruments for colorectal cancer (CRC) patients and to provide recommendations on the choice of HRQOL instruments. STUDY DESIGN AND SETTING: Systematic review of English language literature published between January 1985 and May 2014 identified through a database search of PubMed, Web of Science, Embase, and Ovid MEDLINE. HRQOL instruments were rated on methodological quality and overall levels of evidence using a Consensus-based Standards for the selection of health Measurement Instrument checklist. RESULTS: Internal consistency and hypothesis testing were evaluated most frequently in 63 studies identified. The Functional Assessment of Cancer Therapy-Colorectal (FACT-C) was the most extensively evaluated. The highest number of positive ratings in the overall level of evidence was found in the CRC-specific quality of life questionnaire module (QLQ-CR38) in European Organization for Research and Treatment of Cancer (EORTC) module, followed by the Memorial Sloan Kettering Cancer Center Bowel instrument, FACT-C, and Quick-FLIC. The EORTC QLQ-CR38 had the most positive ratings on measurement property and was recommended. CONCLUSION: The EORTC QLQ-CR38 was recommended to assess HRQOL in patients with CRC, regardless of disease stage and primary tumor site.
OBJECTIVES: To critically appraise the measurement properties of standardized health-related quality of life (HRQOL) instruments for colorectal cancer (CRC) patients and to provide recommendations on the choice of HRQOL instruments. STUDY DESIGN AND SETTING: Systematic review of English language literature published between January 1985 and May 2014 identified through a database search of PubMed, Web of Science, Embase, and Ovid MEDLINE. HRQOL instruments were rated on methodological quality and overall levels of evidence using a Consensus-based Standards for the selection of health Measurement Instrument checklist. RESULTS: Internal consistency and hypothesis testing were evaluated most frequently in 63 studies identified. The Functional Assessment of Cancer Therapy-Colorectal (FACT-C) was the most extensively evaluated. The highest number of positive ratings in the overall level of evidence was found in the CRC-specific quality of life questionnaire module (QLQ-CR38) in European Organization for Research and Treatment of Cancer (EORTC) module, followed by the Memorial Sloan Kettering Cancer Center Bowel instrument, FACT-C, and Quick-FLIC. The EORTC QLQ-CR38 had the most positive ratings on measurement property and was recommended. CONCLUSION: The EORTC QLQ-CR38 was recommended to assess HRQOL in patients with CRC, regardless of disease stage and primary tumor site.
Authors: Isamme AlFayyad; Mohamad Al-Tannir; Jude Howaidi; Dana AlTannir; Amani Abu-Shaheen Journal: Qual Life Res Date: 2022-04-30 Impact factor: 3.440
Authors: Vithusha Ganesh; Arnav Agarwal; Marko Popovic; David Cella; Rachel McDonald; Sherlyn Vuong; Henry Lam; Leigha Rowbottom; Stephanie Chan; Tasneem Barakat; Carlo DeAngelis; Michael Borean; Edward Chow; Andrew Bottomley Journal: Support Care Cancer Date: 2016-05-18 Impact factor: 3.603
Authors: Antonia V Bennett; Kathleen Keenoy; Marwan Shouery; Ethan Basch; Larissa K Temple Journal: Qual Life Res Date: 2015-11-21 Impact factor: 4.147
Authors: Pia Näsvall; Ursula Dahlstrand; Thyra Löwenmark; Jörgen Rutegård; Ulf Gunnarsson; Karin Strigård Journal: Qual Life Res Date: 2016-07-21 Impact factor: 4.147
Authors: B Romain; O Rohmer; S Schimchowitsch; M Hübner; J B Delhorme; C Brigand; S Rohr; D Guenot Journal: Health Qual Life Outcomes Date: 2018-01-17 Impact factor: 3.186
Authors: Susan E M van Dijk; Marcel C Adriaanse; Lennart van der Zwaan; Judith E Bosmans; Harm W J van Marwijk; Maurits W van Tulder; Caroline B Terwee Journal: Qual Life Res Date: 2018-02-02 Impact factor: 4.147
Authors: Samantha J Mason; James W F Catto; Amy Downing; Sarah E Bottomley; Adam W Glaser; Penny Wright Journal: BJU Int Date: 2018-06-08 Impact factor: 5.588